AQEMIA is a next-gen pharmatech company generating one of the world's fastest-growing drug discovery pipeline. Our mission is to design fast innovative drug candidates for dozens of critical diseases, such as immuno-oncology.
Our unique approach leverages quantum-inspired physics algorithms to power generative AI in designing novel drug candidates—without relying on experimental data. We already delivered several drug discovery successes within our internal pipeline and through collaborations with pharmaceutical companies.
Our most advanced programs are currently in vivo optimization.
Aqemia is proud to be part of the French Tech 120 program, which supports the most promising scale-ups in France with high potential for global impact.
AQEMIA is based in Paris and London.
We are growing and hiring! Check our career website: https://jobs.lever.co/aqemia.com
Discover the roles and behind-the-scenes at AQEMIA on our Welcome To The Jungle page: https://www.welcometothejungle.com/fr/companies/aqemia
Company Details
- Employees
- 78
- Founded
- -
- Address
- 1 Boulevard Pasteur, Paris,île-De-France 75015,france
- ma****@****mia.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- aqemia.com
- Keywords
- Pharmaceutical R&D, Artificial intelligence, drug hunting, drug design, Physics Based Technology, Quantum Physics, Machine Learning, Pharmaceuticals, PharmaTech, TechBio, Tech Platform, Computational Chemistry, Atomic Scale, Oncology, Cancer, Immuno-Oncology, AI Drug Discovery, Generative AI, Drug Discovery.
- HQ
- Paris, Île-de-France
Aqemia Questions
Aqemia's website is aqemia.com
Aqemia's LinkedIn profile is https://fr.linkedin.com/company/aqemia
Aqemia has
78 employees.
View email and phone details for 78
employees at Aqemia.
Aqemia's industry is
Biotechnology Research
Aqemia's top competitors are
Bioptimus,
Owkin,
Prophesee,
Photoroom,
Orakl Oncology,
Whitelab Genomics,
Iktos,
Qubit Pharmaceuticals,
Pasqal,
Mistral Ai.
Aqemia's support email address is maximilien.levesque@aqemia.com
Aqemia's categories are Biotechnology Research
Aqemia's founding year is 2019
